PT Indofarma Tbk (ISX:INAF) Gross Margin % : -4.12% (As of Sep. 2023)

View and export this data going back to 2001. Start your Free Trial

What is PT Indofarma Tbk Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. PT Indofarma Tbk's Gross Profit for the three months ended in Sep. 2023 was Rp-3,366 Mil. PT Indofarma Tbk's Revenue for the three months ended in Sep. 2023 was Rp81,737 Mil. Therefore, PT Indofarma Tbk's Gross Margin % for the quarter that ended in Sep. 2023 was -4.12%.

The historical rank and industry rank for PT Indofarma Tbk's Gross Margin % or its related term are showing as below:

ISX:INAF' s Gross Margin % Range Over the Past 10 Years
Min: -25.73 Med: 19.14 Max: 25.24
Current: -25.73

During the past 13 years, the highest Gross Margin % of PT Indofarma Tbk was 25.24%. The lowest was -25.73%. And the median was 19.14%.

ISX:INAF's Gross Margin % is ranked worse than
96.86% of 987 companies
in the Drug Manufacturers industry
Industry Median: 46.53 vs ISX:INAF: -25.73

PT Indofarma Tbk had a gross margin of -4.12% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for PT Indofarma Tbk was 0.00% per year.

PT Indofarma Tbk Gross Margin % Historical Data

The historical data trend for PT Indofarma Tbk's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Indofarma Tbk Gross Margin % Chart

PT Indofarma Tbk Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Gross Margin %

Get a 7-Day Free Trial

17.84

18.42

23.35

15.56

-9.62

PT Indofarma Tbk Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Gross Margin %	Get a 7-Day Free Trial															1.46	-77.94	2.55	4.78	-4.12

Competitive Comparison of PT Indofarma Tbk's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Indofarma Tbk's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's Gross Margin % distribution charts can be found below:

* The bar in red indicates where PT Indofarma Tbk's Gross Margin % falls into.

PT Indofarma Tbk Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

PT Indofarma Tbk's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )	=	Gross Profit (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-110108.7	/	1144108.231
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(1144108.231 - 1254216.942)	/	1144108.231
	=	-9.62 %

PT Indofarma Tbk's Gross Margin for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )	=	Gross Profit (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-3365.9	/	81736.853
	=	(Revenue - Cost of Goods Sold)	/	Revenue
	=	(81736.853 - 85102.72)	/	81736.853
	=	-4.12 %

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

PT Indofarma Tbk (ISX:INAF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

PT Indofarma Tbk had a gross margin of -4.12% for the quarter that ended in Sep. 2023 => No sustainable competitive advantage

Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.

PT Indofarma Tbk Gross Margin % Related Terms

Thank you for viewing the detailed overview of PT Indofarma Tbk's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Indofarma Tbk (ISX:INAF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Indofarma Tbk (ISX:INAF) » Definitions » Gross Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jalan Indofarma No. 1, Cikarang Barat, Jawa Bara, Bekasi, IDN, 17530

Website

http://www.indofarma.id

PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others, Pharmaceutical Engineering, and Aliansi Strategis Segment. The Medicine business segment includes drug production, marketing and distribution and sales. The Medical Device Segment includes medical devices and other products. The Pharmaceutical Engineering Segment includes the sale and maintenance of packaging machines for the pharmaceutical industry to external parties.

PT Indofarma Tbk (ISX:INAF) Headlines

No Headlines